AbbVie to Present at the Leerink Partners Global Healthcare Conference
AbbVie (NYSE: ABBV) will participate in the Leerink Partners Global Healthcare Conference on Tuesday, March 10, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
AbbVie (NYSE: ABBV) will participate in the Leerink Partners Global Healthcare Conference on Tuesday, March 10, 2026. Management will take part in a fireside chat at 10:20 a.m. Central Time. A live audio webcast will be available via AbbVie's Investor Relations site, with an archived edition posted later that day.
Details
News Market Reaction – ABBV
On Mar 3, the day this news came out, ABBV closed 0.17% below the previous close.
Data tracked by StockTitan Argus for the Mar 3 session.
Key Figures
- Conference date
- March 10, 2026
- Leerink Partners Global Healthcare Conference appearance
- Fireside chat time
- 10:20 a.m. Central Time
- Scheduled AbbVie management session at conference
Historical Context
-
Positive Phase 3 AFFIRM SKYRIZI Crohn’s data with strong remission rates.
-
Participation in TD Cowen health care conference fireside chat.
-
Plans to invest $380M in new U.S. API facilities, adding 300 jobs.
-
FDA approval of VENCLEXTA plus acalabrutinib combo for first-line CLL.
-
Quarterly cash dividend of $1.73 per share with long-term growth track.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.
Media: Gabby Tarbert (224) 244-0111 | Investors: Liz Shea |
View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-leerink-partners-global-healthcare-conference-302701106.html
SOURCE AbbVie
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.